St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
565 hedge funds and large institutions have $15.9B invested in St Jude Medical in 2014 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 185 increasing their positions, 232 reducing their positions, and 32 closing their positions.
119% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 32
47% more call options, than puts
Call options by funds: $72.4M | Put options by funds: $49.2M
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
6% more funds holding
Funds holding: 534 → 565 (+31)
3% more capital invested
Capital invested by funds: $15.4B → $15.9B (+$479M)
20% less repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 232
Top Buyers
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$98.6M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$93.4M |
| 3 |
Two Sigma Investments
New York
|
+$74.4M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$70.2M |
| 5 |
Millennium Management
New York
|
+$55.6M |
Top Sellers
STJ Hedge Fund Activity: Q1 2014 in Review
565 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q1 2014, worth a combined $15.9B — up 3.1% from $15.4B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new STJ positions and 32 closed out — a net gain of 38 holders — while 185 added to existing stakes and 232 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $98.6M. The largest seller was Capital Research Global Investors, cutting an estimated $460M.
- 565 institutional investors held St Jude Medical (STJ) as of Q1 2014, up from 534 in Q4 2013.
- Funds reported $15.9B of St Jude Medical stock for Q1 2014, up 3.1% quarter-over-quarter.
- 70 funds opened new St Jude Medical positions in Q1 2014 and 32 closed out, a net change of +38 holders.
- The largest St Jude Medical buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $98.6M added.
- The largest St Jude Medical seller in Q1 2014 was Capital Research Global Investors, an estimated $460M sold.
Based on aggregated 13F filings for Q1 2014.